NOWEDA FINED BY CARTEL OFFICE

9 March 1992

The German drug wholesaler, Noweda, has been fined 3.1 million Deutschemarks ($1.9 million) by the Federal Cartel Office (BKA) for entering into agreements with other drug wholesalers to cut discounts, an action said to increase the pharmacy purchasing prices for drug products.

There are around 12 other companies which are thought to have been involved in the period between 1987 and 1990. These companies have been fined a total of 34 million marks. The fines are now said to be due because the companies have withdrawn their appeals, according to local reports.

Noweda has said it plans to appeal as no such agreements were made, and discount trends in the years in question were not to the disadvantage of pharmacists.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight